By every measure the demand for enantiomerically pure intermediates for the synthesis of chiral pharmaceutical substances is increasing. Discovery of new catalytic reactions, especially those which would yield practical levels of asymmetric induction with high catalyst turnover frequencies (i.e., substrate/catalyst/unit time), will have significant impact on medicinal as well as process chemistry. Invention of new methods for chirality transfer between catalysts and substrates is at the heart of discovery in practical asymmetric synthesis. Through an approach that relies primarily on mechanistic insights and systematic examination of ligand effects, a number of protocols for the enantioselective heterodimerization reactions of ethylene with various alkenes have been discovered. An important class of substrates that did not work well in our earlier attempts is 1,3-dienes, which are among the most accessible and potentially useful starting materials. The primary products of their asymmetric reactions can be further elaborated into more complex molecules. Yet, outside Diels-Alder reactions, few broadly applicable asymmetric catalyzed, intermolecular carbon-carbon bond-forming reactions of 1,3-dienes are known, partly because of the conformational mobility of these compounds. We recently discovered innovative methods to effect highly regio- and enantio-selective asymmetric hydrovinylation (addition of ethylene) of different classes of 1,3-dienes, including highly functionalized ones, using Ni(II)-, Co(II)- and Ru(II)-catalysts. This chemistry, when fully implemented, will provide access to wide variety of enantio-pure, ubiquitous chemical intermediates. The goal of this proposal is to explore the applications of these reactions and the resulting intermediates for the synthesis of compounds with proven biological efficacy. Examples illustrated include powerful anti-microbial and anti-tumor agents, GABA analogs, metalloproteinase inhibitors. Applications of the newly discovered reactions for the efficient syntheses of several broad classes of medicinally relevant compounds are proposed. In summary, the proposed research will provide powerful tools for the synthesis of biologically relevant targets and their congeners, by revealing new ways of accessing reactive enantio-pure intermediates such as skipped-1,4-dienes, enol-ethers, enol-acetates, vinylstannes and vinylsilanes. These intermediates could be useful for making new structures or advanced structural analogs of well-known compounds for testing. We hope that the discoveries made will shorten the considerable distance between the conceptualization of a molecule as a drug candidate and its large-scale synthesis.

Public Health Relevance

The proposed research will provide powerful tools for the synthesis of pharmaceutically relevant compounds and their congeners, in addition to providing broadly applicable, novel enantioselective routes to versatile reactive intermediates like silyl enol ethers and vinyl organometallics from 1,3- dienes. Since highly catalytic reactions and readily available precursors are involved in the proposed new processes, successful conclusion of this project will also add to our repertoire of synthetic methods useful for large scale manufacture of useful pharmaceutical intermediates. This effort will result in tangible economic and environmental benefits. We hope that the discoveries made will shorten the considerable distance between the conceptualization of a molecule as a drug candidate and its large-scale synthesis.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM108762-02
Application #
9100792
Study Section
Synthetic and Biological Chemistry B Study Section (SBCB)
Program Officer
Lees, Robert G
Project Start
2015-07-01
Project End
2019-06-30
Budget Start
2016-07-01
Budget End
2017-06-30
Support Year
2
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Ohio State University
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
832127323
City
Columbus
State
OH
Country
United States
Zip Code
43210
Pagar, Vinayak Vishnu; RajanBabu, T V (2018) Tandem catalysis for asymmetric coupling of ethylene and enynes to functionalized cyclobutanes. Science 361:68-72
Tenneti, Srinivasarao; Biswas, Souvagya; Cox, Glen Adam et al. (2018) Broadly Applicable Stereoselective Syntheses of Serrulatane, Amphilectane Diterpenes, and Their Diastereoisomeric Congeners Using Asymmetric Hydrovinylation for Absolute Stereochemical Control. J Am Chem Soc 140:9868-9881
Jing, Stanley M; Balasanthiran, Vagulejan; Pagar, Vinayak et al. (2017) Catalytic Enantioselective Hetero-dimerization of Acrylates and 1,3-Dienes. J Am Chem Soc 139:18034-18043
Li, Ke; Scott, Anne M; Brant, Cory O et al. (2017) Bile Salt-like Dienones Having a Novel Skeleton or a Rare Substitution Pattern Function as Chemical Cues in Adult Sea Lamprey. Org Lett 19:4444-4447
Xu, Feng; Xiao, Xiao; Hoye, Thomas R (2017) Photochemical Hexadehydro-Diels-Alder Reaction. J Am Chem Soc 139:8400-8403
Raya, Balaram; Jing, Stanley; RajanBabu, T V (2017) Control of Selectivity through Synergy between Catalysts, Silanes and Reaction Conditions in Cobalt-Catalyzed Hydrosilylation of Dienes and Terminal Alkenes. ACS Catal 7:2275-2283
Raya, Balaram; Biswas, Souvagya; RajanBabu, T V (2016) Selective Cobalt-Catalyzed Reduction of Terminal Alkenes and Alkynes Using (EtO)2Si(Me)H as a Stoichiometric Reductant. ACS Catal 6:6318-6323
Biswas, Souvagya; Page, Jordan P; Dewese, Kendra R et al. (2015) Asymmetric Catalysis with Ethylene. Synthesis of Functionalized Chiral Enolates. J Am Chem Soc 137:14268-71